BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 31352238)

  • 21. Long non-coding RNA CASC15 regulates gastric cancer cell proliferation, migration and epithelial mesenchymal transition by targeting CDKN1A and ZEB1.
    Wu Q; Xiang S; Ma J; Hui P; Wang T; Meng W; Shi M; Wang Y
    Mol Oncol; 2018 Jun; 12(6):799-813. PubMed ID: 29489064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FOXD1-AS1 regulates FOXD1 translation and promotes gastric cancer progression and chemoresistance by activating the PI3K/AKT/mTOR pathway.
    Wu Q; Ma J; Wei J; Meng W; Wang Y; Shi M
    Mol Oncol; 2021 Jan; 15(1):299-316. PubMed ID: 32460412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-149 reverses cisplatin resistance of gastric cancer SGC7901/DDP cells by targeting FoxM1.
    Li X; Liang J; Liu YX; Wang Y; Yang XH; Luan BH; Zhang GL; Du J; Wu XH
    Pharmazie; 2016 Nov; 71(11):640-643. PubMed ID: 29441968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Propofol facilitates cisplatin sensitivity via lncRNA MALAT1/miR-30e/ATG5 axis through suppressing autophagy in gastric cancer.
    Zhang YF; Li CS; Zhou Y; Lu XH
    Life Sci; 2020 Mar; 244():117280. PubMed ID: 31926239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Knockdown of long non-coding RNA HOTAIR reverses cisplatin resistance of ovarian cancer cells through inhibiting miR-138-5p-regulated EZH2 and SIRT1.
    Zhang Y; Ai H; Fan X; Chen S; Wang Y; Liu L
    Biol Res; 2020 Apr; 53(1):18. PubMed ID: 32349783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET.
    Chen QY; Jiao DM; Wang J; Hu H; Tang X; Chen J; Mou H; Lu W
    Oncotarget; 2016 Apr; 7(17):24510-26. PubMed ID: 27014910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-101 alleviates chemoresistance of gastric cancer cells by targeting ANXA2.
    Bao J; Xu Y; Wang Q; Zhang J; Li Z; Li D; Li J
    Biomed Pharmacother; 2017 Aug; 92():1030-1037. PubMed ID: 28609840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HOXD-AS1 confers cisplatin resistance in gastric cancer through epigenetically silencing PDCD4 via recruiting EZH2.
    Ye Y; Yang S; Han Y; Sun J; Xv L; Wu L; Ming L
    Open Biol; 2019 Sep; 9(9):190068. PubMed ID: 31551012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long noncoding RNA SOX2OT contributes to gastric cancer progression by sponging miR-194-5p from AKT2.
    Qu F; Cao P
    Exp Cell Res; 2018 Aug; 369(2):187-196. PubMed ID: 29782828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-21 modulates cisplatin resistance of gastric cancer cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway.
    Gu Y; Fei Z; Zhu R
    Anticancer Drugs; 2020 Apr; 31(4):385-393. PubMed ID: 31913198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression.
    Wang X; Li H; Shi J
    Biomed Res Int; 2019; 2019():8645153. PubMed ID: 31275988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CircUGGT2 downregulation by METTL14-dependent m
    Chen XY; Yang YL; Yu Y; Chen ZY; Fan HN; Zhang J; Zhu JS
    Pharmacol Res; 2024 Jun; 204():107206. PubMed ID: 38729588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circular RNA circVAPA promotes chemotherapy drug resistance in gastric cancer progression by regulating miR-125b-5p/STAT3 axis.
    Deng P; Sun M; Zhao WY; Hou B; Li K; Zhang T; Gu F
    World J Gastroenterol; 2021 Feb; 27(6):487-500. PubMed ID: 33642823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-874-3p represses the migration and invasion yet promotes the apoptosis and cisplatin sensitivity via being sponged by long intergenic non-coding RNA 00922 (LINC00922) and targeting Glycerophosphodiester Phosphodiesterase Domain Containing 5 (GDPD5) in gastric cancer cells.
    Zhang X; Dai X; Zhao X; Wang J; Dou J; Zhuang H; Chen N; Zhao H
    Bioengineered; 2022 Mar; 13(3):7082-7104. PubMed ID: 35282764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long Noncoding RNA CAT104 Promotes Cell Viability, Migration, and Invasion in Gastric Carcinoma Cells Through Activation of MicroRNA-381-Inhibiting Zinc Finger E-box-Binding Homeobox 1 (ZEB1) Expression.
    Yuan G; Quan J; Dong D; Wang Q
    Oncol Res; 2018 Aug; 26(7):1037-1046. PubMed ID: 29295724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long non-coding RNA ROR regulated ABCB1 to induce cisplatin resistance in osteosarcoma by sponging miR-153-3p.
    Cheng FH; Zhao ZS; Liu WD
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7256-7265. PubMed ID: 31539112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The long noncoding RNA CRAL reverses cisplatin resistance via the miR-505/CYLD/AKT axis in human gastric cancer cells.
    Wang Z; Wang Q; Xu G; Meng N; Huang X; Jiang Z; Chen C; Zhang Y; Chen J; Li A; Li N; Zou X; Zhou J; Ding Q; Wang S
    RNA Biol; 2020 Nov; 17(11):1576-1589. PubMed ID: 31885317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LncRNA ADAMTS9-AS2 inhibits gastric cancer (GC) development and sensitizes chemoresistant GC cells to cisplatin by regulating miR-223-3p/NLRP3 axis.
    Ren N; Jiang T; Wang C; Xie S; Xing Y; Piao D; Zhang T; Zhu Y
    Aging (Albany NY); 2020 Jun; 12(11):11025-11041. PubMed ID: 32516127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA SNHG5 promotes cisplatin resistance in gastric cancer via inhibiting cell apoptosis.
    Li M; Zhang YY; Shang J; Xu YD
    Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4185-4191. PubMed ID: 31173289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LncRNA SNHG1 promotes tumor progression and cisplatin resistance through epigenetically silencing miR-381 in breast cancer.
    Zhang M; Yang L; Hou L; Tang X
    Bioengineered; 2021 Dec; 12(2):9239-9250. PubMed ID: 34806925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.